BioLineRx annual depreciation and amortization
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
BioLineRx Depreciation & Amortization Growth & History (BLRX)
BioLineRx's depreciation and amortization was $495,000 for fiscal 2025.
View full BioLineRx company overviewBioLineRx annual depreciation and amortization history
| Fiscal year | Period ended | Depreciation and amortization | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $495,000 | $64,000 | +14.85% |
| 2024 | 2024-12-31 | $431,000 | −$152,000 | −26.07% |
| 2023 | 2023-12-31 | $583,000 | −$32,000 | −5.20% |
| 2022 | 2022-12-31 | $615,000 | −$45,000 | −6.82% |
| 2021 | 2021-12-31 | $660,000 | −$204,000 | −23.61% |
| 2020 | 2020-12-31 | $864,000 | $2,000 | +0.23% |
| 2019 | 2019-12-31 | $862,000 | $438,000 | +103.30% |
| 2018 | 2018-12-31 | $424,000 | −$28,000 | −6.19% |
| 2017 | 2017-12-31 | $452,000 | $0 | 0.00% |
| 2016 | 2016-12-31 | $452,000 | $38,000 | +9.18% |
| 2015 | 2015-12-31 | $414,000 | — | — |
BioLineRx quarterly depreciation and amortization
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Depreciation and amortization | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $78,000 | −$98,000 | −55.68% |
| Q1 2026 | 2026-03-31 | $88,000 | −$77,000 | −46.67% |
| Q4 2025 | 2025-12-31 | $63,000 | — | — |
| Q3 2025 | 2025-09-30 | $119,000 | — | — |
| Q2 2025 | 2025-06-30 | $176,000 | — | — |
| Q1 2025 | 2025-03-31 | $165,000 | — | — |
BioLineRx depreciation and amortization trends
Over the last five fiscal years, BioLineRx's depreciation and amortization decreased from $864,000 to $495,000, a change of −$369,000. The latest reported quarter, Q2 2026, shows $78,000.
About the metric
What depreciation and amortization mean
Depreciation and amortization allocate the cost of tangible and intangible assets over their useful lives. These non-cash expenses reduce reported earnings and are commonly added back when calculating EBITDA and operating cash flow.
Calculation and source
Reported depreciation and amortization
TickerStat uses a combined depreciation and amortization value when reported. If a company reports the two components separately for an aligned period, they are added together without duplicating overlapping facts. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review BioLineRx source filings ↗